GAITHERSBURG, Md., May 4, 2023
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company
advancing protein-based vaccines with its novel Matrix-M™ adjuvant,
today announced that it will participate in the BofA Securities
2023 Health Care Conference.
|
Conference
Details:
|
|
Fireside
Chat
|
|
Date:
|
Thursday, May 11,
2023
|
|
Time:
|
10:00 – 10:30 a.m.
Pacific Daylight Time (PDT)
|
|
Location:
|
Encore Hotel in Las
Vegas, Nevada
|
|
Moderator:
|
Alec Stranahan, Ph.D.,
Equity Research Analyst – Biotechnology
|
|
Novavax
participants:
|
John C. Jacobs,
President and Chief Executive Officer and
Filip Dubovsky, M.D.,
President, Research & Development
|
|
|
|
Conference
|
|
|
Event:
|
Investor
Meetings
|
|
Date:
|
Wednesday, May 10, 2023
- Thursday, May 11, 2023
|
Recordings
A replay of the recorded fireside session
will be available through the Events & presentations page of
the Company's website at ir.novavax.com for 90 days from the
date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes
improved health by discovering, developing and commercializing
innovative vaccines to protect against serious infectious diseases.
Novavax, a global company based in Gaithersburg, Md., U.S., offers a
differentiated vaccine platform that combines a recombinant protein
approach, innovative nanoparticle technology and Novavax's patented
Matrix-M adjuvant to enhance the immune response. Focused on the
world's most urgent health challenges, Novavax is currently
evaluating vaccines for COVID-19, influenza, and COVID-19 and
influenza combined.
Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Erika Schultz | 240-268-2022
ir@novavax.com
Media
Ali Chartan or Giovanna Chandler | 240-709-5563
media@novavax.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-bofa-securities-2023-health-care-conference-301816524.html
SOURCE Novavax, Inc.